maritide glp-1 A GIPR antagonist conjugated to analogs promotes weight loss with improved metabolic parameters in preclinical and phase I settings New Drug MariTide Shows Promising

Metabolic Associated Steatotic Liver Disease has emerged as the leading cause of liver damage worldwide, affecting approximately 25% of the global adult population (American Liver Foundation, 2022)

the British Medical Journal also argues that preserving muscle mass and physical function should also be a central goal of obesity treatment instead of focusing only on weight loss

Contact us today at (816) 214-5260 or email [email protected] to schedule a consultation and explore how GLP-1 medications and peptides can be integrated into your personalized weight loss plan

Our Metabolic Assessment Process Before initiating GLP-1 therapy, we conduct a thorough metabolic evaluation

Alternative medications Semaglutide can be costly, but there are cheaper alternatives, including GLP-1 and non-GLP-1 medications

These medications work best with consistent dosing, and irregular use can worsen rebound symptoms when you resume